治疗慢性髓系白血病的新型靶向药——Asciminib
First-in-class targeted agent for chronic myeloid leukemia—— asciminb
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |